LRA Ventures LLC 13D and 13G filings for Enfusion, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-10-25 4:30 pm Sale | 2024-09-30 | 13G | Enfusion, Inc. ENFN | LRA Ventures LLC | 6,184,271 6.300% | -1,787,736![]() (-22.43%) | Filing |
2024-02-07 08:00 am Sale | 2023-12-31 | 13G | Enfusion, Inc. ENFN | LRA Ventures LLC | 7,972,007 8.460% | -2,898,379![]() (-26.66%) | Filing |
2023-02-13 5:15 pm Sale | 2022-12-31 | 13G | Enfusion, Inc. ENFN | LRA Ventures LLC | 10,870,386 13.940% | -1,000,000![]() (-8.42%) | Filing |
2022-02-18 07:00 am Purchase | 2021-12-31 | 13G | Enfusion, Inc. ENFN | LRA Ventures LLC | 11,870,386 15.330% | 11,870,386![]() (New Position) | Filing |